S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
Log in

LON:IBT - International Biotechnology Trust Share Price, Forecast & News

GBX 632
+12.00 (+1.94 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
622
Now: GBX 632
634
50-Day Range
6.62
MA: GBX 614.87
642
52-Week Range
5.79
Now: GBX 632
661.84
Volume51,607 shs
Average Volume37,914 shs
Market Capitalization£243.68 million
P/E Ratio13.06
Dividend Yield4.49%
BetaN/A
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. Read More…

Industry, Sector and Symbol

Industry Asset Management
Sub-IndustryN/A
SectorFinancial Services
CUSIPN/A
CIKN/A
Phone44 20 7421 7070

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£21.68 million
Cash FlowGBX 29.41 per share
Book ValueGBX 624 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap£243.68 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IBT News and Ratings via Email

Sign-up to receive the latest news and ratings for IBT and its competitors with MarketBeat's FREE daily newsletter.


International Biotechnology Trust (LON:IBT) Frequently Asked Questions

What is International Biotechnology Trust's stock symbol?

International Biotechnology Trust trades on the London Stock Exchange (LON) under the ticker symbol "IBT."

How often does International Biotechnology Trust pay dividends? What is the dividend yield for International Biotechnology Trust?

International Biotechnology Trust announced a dividend on Wednesday, December 11th. Investors of record on Thursday, December 19th will be given a dividend of GBX 12.40 per share on Friday, January 31st. This represents a yield of 1.96%. The ex-dividend date of this dividend is Thursday, December 19th. The official announcement can be accessed at this link. View International Biotechnology Trust's Dividend History.

Has International Biotechnology Trust been receiving favorable news coverage?

Headlines about IBT stock have trended somewhat positive this week, InfoTrie reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. International Biotechnology Trust earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for International Biotechnology Trust.

Who are some of International Biotechnology Trust's key competitors?

What other stocks do shareholders of International Biotechnology Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other International Biotechnology Trust investors own include Oxford Pharmascience Group (OXP), Provident Financial (PFG), Berkeley Group (BKG), Aberdeen Asset Management (ADN), GLI Finance (GLIF), Hurricane Energy (HUR), Phoenix Group (PHNX), Riverstone Energy (RSE), Solo Oil (SOLO) and Acerus Pharmaceuticals (TRLPF).

Who are International Biotechnology Trust's key executives?

International Biotechnology Trust's management team includes the folowing people:
  • Ms. Lucy Cost Duarte, Head of Investor Relations
  • Ms. Kate Bingham, Managing Partner (Age 53)
  • Ms. Ailsa Craig, Investment Mang.
  • Dr. Carl Harald Janson, Lead Investment Mang.

How do I buy shares of International Biotechnology Trust?

Shares of IBT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is International Biotechnology Trust's stock price today?

One share of IBT stock can currently be purchased for approximately GBX 632.

How big of a company is International Biotechnology Trust?

International Biotechnology Trust has a market capitalization of £243.68 million and generates £21.68 million in revenue each year. View Additional Information About International Biotechnology Trust.

What is International Biotechnology Trust's official website?

The official website for International Biotechnology Trust is http://www.ibtplc.com/.

How can I contact International Biotechnology Trust?

International Biotechnology Trust's mailing address is 10 Harewood Avenue, LONDON, NW1 6AA, United Kingdom. The company can be reached via phone at 44 20 7421 7070.


MarketBeat Community Rating for International Biotechnology Trust (LON IBT)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  133 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  209
MarketBeat's community ratings are surveys of what our community members think about International Biotechnology Trust and other stocks. Vote "Outperform" if you believe IBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IBT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Featured Article: Growth Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel